How to evaluate online GLP-1 care
Online GLP-1 programs can differ in much more than their advertised monthly price. The useful comparison is the complete service: medical review, medication, pharmacy, fulfillment, and ongoing care.
1. Verify the clinical review
Ask which clinician group reviews your information and whether that clinician is licensed for your state. A short intake can be convenient, but it should still collect your medical history, current medications, allergies, and relevant conditions. The clinician should be able to reject a requested treatment or recommend an alternative.
2. Know exactly what is being prescribed
Semaglutide and tirzepatide appear in FDA-approved products and in compounded preparations. These are not interchangeable categories. The FDA states that compounded drugs are not FDA-approved and are not reviewed for safety, effectiveness, or quality before marketing.
- Ask for the active ingredient, formulation, concentration, and whether the product is branded or compounded.
- Ask which pharmacy prepares or dispenses it and where that pharmacy is licensed.
- Review the applicable prescribing information and contraindications with your clinician.
3. Compare the total cost, not the headline
| Cost item | Question to ask |
|---|---|
| Clinical care | Is the initial review included? Are follow-ups billed separately? |
| Medication | Does the price change with dose, formulation, or supply length? |
| Program fees | Is a membership required? What is the minimum commitment? |
| Fulfillment | Are shipping, refrigeration, and supplies included? |
| Testing | Are laboratory tests included, optional, or billed separately? |
4. Check storage and delivery procedures
Product labeling for injectable GLP-1 medications includes storage and temperature requirements. Do not use a product that arrives warm or shows signs of inadequate refrigeration, and ask the dispensing pharmacy how replacements are handled. Before ordering, ask how the package is cooled and what to check on arrival.
5. Understand dosing and follow-up support
The FDA has reported dosing errors with compounded injectable semaglutide, including confusion among milligrams, milliliters, and syringe units. Ask for clear instructions specific to the dispensed concentration. Confirm who can answer administration questions and how dose changes are reviewed.
6. Use this checklist before checkout
- The clinician and state-licensure process are identified.
- The medication, formulation, concentration, and pharmacy are disclosed.
- Compounded status and FDA limitations are clear.
- The full ongoing cost and cancellation terms are visible.
- Shipping, storage, and replacement procedures are explained.
- Follow-up, side-effect review, and escalation paths are clear.
- No one promises a prescription or a specific outcome.
Where ArgoMD fits
ArgoMD publishes separate information for semaglutide, tirzepatide, and its care process. Use the checklist above to compare those details with any other provider. Treatment is available only after an individual provider determines it is appropriate.
Frequently asked questions
Do online GLP-1 treatments require a prescription?
Yes. A licensed clinician should review your health history and decide whether a prescription is appropriate. Completing an intake or paying for a program should not guarantee a prescription.
Are compounded semaglutide and tirzepatide FDA-approved?
No. The FDA does not review compounded drugs for safety, effectiveness, or quality before they are marketed. FDA-approved brand products have separate labeling and prescribing information.
Is the lowest advertised price the full cost?
Not always. Compare consultation fees, medication, shipping, membership requirements, dose-related price changes, laboratory costs, and cancellation terms.
What should I ask about follow-up care?
Ask who answers clinical questions, how side effects are reviewed, whether dose changes require another review, and when you should seek in-person or urgent care.
What does microdose GLP-1 mean?
Programs may use this term for lower-dose approaches. Ask for the exact dose, the evidence supporting that use, and the clinician’s plan for monitoring rather than relying on the label alone.
Does ArgoMD guarantee a prescription?
No. ArgoMD treatment requires an individual provider review. A provider may decide that a requested treatment is not appropriate.
Clinical questions to ask before starting or changing a GLP-1 plan
General educational information, not personal medical advice. A licensed provider should review individual health history, current medications, and treatment eligibility.
How do semaglutide and tirzepatide differ?
Semaglutide acts on GLP-1 receptors. Tirzepatide acts on both GIP and GLP-1 receptors. They are different active ingredients, not different brand names for the same medicine. Specific FDA-approved products have distinct indications, formulations, dosing instructions, warnings, and Medication Guides. Approval for one use, such as type 2 diabetes, should not be confused with approval for chronic weight management. Compounded preparations are not FDA-approved. A provider should determine whether either medication is appropriate, and doses should not be substituted or converted between medications without clinical direction.1236
What side effects and medical history should be discussed before treatment?
Ask about both common effects and the serious warnings in the exact product's Medication Guide. Nausea, vomiting, diarrhea, constipation, and abdominal symptoms are listed for semaglutide and tirzepatide. The history review can include allergies, all prescription and nonprescription products, supplements, prior pancreatitis, gallbladder or kidney disease, severe stomach problems, diabetic retinopathy, pregnancy or breastfeeding, pregnancy plans, thyroid tumors, and Multiple Endocrine Neoplasia syndrome type 2. People using insulin or a sulfonylurea should also ask about low blood sugar risk.23
Ask which symptoms require prompt clinical contact, urgent care, or emergency services. MedlinePlus lists warning signs such as severe or persistent abdominal pain, difficulty breathing or swallowing, swelling of the face or throat, fainting, vision changes, and decreased urination, with differences by medication. The dispensing pharmacy and prescribing provider should explain the instructions for the specific product.23
Can an asynchronous online intake be enough for a prescription decision?
An online questionnaire can collect useful information, but submitting one is not itself a prescription decision. The reviewer should be licensed or otherwise legally permitted to care for patients in the patient's state. State telehealth and prescribing requirements vary, and a clinician may decide that a live conversation, records, laboratory results, or an in-person evaluation is needed. Before checkout, ask who reviews the intake, how follow-up questions are handled, and how urgent concerns are routed. Payment or quiz completion should never guarantee a prescription.5
How should nutrition and muscle preservation be discussed?
Ask for a practical nutrition and activity review rather than assuming medication replaces either one. A clinician or registered dietitian can review food intake, protein sources, fluids, gastrointestinal symptoms, dietary restrictions, and changes in strength or function. Resistance activity can be discussed in the context of individual abilities and health conditions. The Physical Activity Guidelines for Americans includes muscle-strengthening activity on at least 2 days each week as a general adult guideline, not an individualized prescription. Also ask what to do if nausea, vomiting, diarrhea, or reduced appetite interferes with eating or drinking.14
What should be shared when switching clinics or restarting after a treatment gap?
Provide the exact medication name, whether it was FDA-approved or compounded, formulation, concentration, most recent dose, last dose date, prior schedule, side effects, and the reason for the gap or switch. Include the previous pharmacy instructions when available. Do not assume that a new provider will continue the same dose or that milligrams can be matched across different drugs or formulations. Missed-dose instructions vary by product, so use the current prescription directions and ask the prescriber or pharmacist before taking a late or extra dose. The new provider may request records or select a different starting schedule after review.23
Sources for clinical questions
- National Institute of Diabetes and Digestive and Kidney Diseases, "Prescription Medications to Treat Overweight and Obesity."
- MedlinePlus, "Semaglutide Injection."
- MedlinePlus, "Tirzepatide Injection."
- Office of Disease Prevention and Health Promotion, "Top 10 Things to Know About the Physical Activity Guidelines for Americans."
- Telehealth.HHS.gov, "Licensing Across State Lines."
- US Food and Drug Administration, "FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss."
Sources
- FDA: Concerns with unapproved GLP-1 drugs
- FDA: Dosing errors associated with compounded injectable semaglutide
- NIDDK: Prescription medications to treat overweight and obesity
- MedlinePlus: Semaglutide injection
- MedlinePlus: Tirzepatide injection
Published and last reviewed for source accuracy: November 13, 2026. This page provides general information, not personal medical advice.